分享至
简介
基本信息
技术文档
上下游信息
相关文章
评价
咨询
售后
产品简介
Information Verinurad (RDEA3170) Verinurad (RDEA3170) is a high-affinity inhibitor of the URAT1 transporter with an IC50 of 25 nM for inhibiting transport activity of human URAT1. It inhibits the related URAT1 homologs OAT4 and OAT1 with approximately 200-fold lower affinity compared to URAT1 with IC50 values of 5.9 µM and 4.6 µM, respectively. Targets URAT1 transporter (Cell-free assay) 25 nM In vitro Verinurad inhibited the transport activity of human URAT1 in a dose-dependent manner, at high potency with an IC50 of 25 nM. Verinurad inhibited the related URAT1 homologs OAT4 and OAT1 with approximately 200-fold lower affinity compared to URAT1 with IC50 values of 5.9 μM and 4.6 μM, respectively. Human URAT1 (IC50=0.025 μM) has a 1,640-fold higher affinity for verinurad compared to rat URAT1(IC50 = 41 μM). Verinurad has a high potency for human URAT1, and residues 35, 365 and 481 all contribute to verinurad affinity. Human URAT1 carrying a chimeric point mutation at position 365, in which human Phe-365 is replaced by rat Tyr-365 (human URAT1-F365Y or h-F365Y) has an IC50 of 4.0 μM, a significant 160-fold lower affinity relative to human URAT1. Meanwhile, rat URAT1 carrying the opposite point mutation (rat URAT1-Y365F or r-Y365F), had an IC50 of 2.9 μM, a significant 14-fold higher affinity compared to rat URAT1. In vivo In human, absorption of a single dose is rapid, and exposure (Cmax and AUC) increases with dose up to the maximum dose tested. Cmax is at 0.5-0.75 hours post dose in the fasted state, and is slightly delayed to 1.25 hours post dose in the fed state. The t1/2 is approximately 10-15 hours across doses. Verinurad was well tolerated at the doses studied. In the systemic circulation, verinurad appeared to be a high clearance drug (CL/F ranged ~30-50 L/h) with extensive extravascular distribution. Renal excretion of verinurad is limited to only ~2%–3% in the urine, suggesting that the majority of verinurad is likely cleared in the liver via biotransformation to metabolites. Cell Research(from reference) Cell lines:HEK-293T cells Concentrations:0.1 nM-1 mM Incubation Time:5 min
中文名称
Verinurad (RDEA3170), 溶质运载家族 22 成员 12 抑制剂
英文名称
Verinurad (RDEA3170)
中文别名
维里努拉德 (RDEA3170)
英文别名
CAS No.:1352792-74-5 | C72401 | SB19753 | CCG-268013 | CEC79274 | BCP17058 | Verinurad (USAN/INN) | D11129 | A906128 | HY-16733 | YYBOLPLTQDKXPM-UHFFFAOYSA-N | BS-15247 | Propanoic acid, 2-((3-(4-cyano-1-naphthalenyl)-4-pyridinyl)thio)-2-methyl- | 1352792
CAS号
1352792-74-5
分子式
C20H16N2O2S
分子量
348.42 g/mol
精确质量
-
PSA
99.300 Ų
Logp
3.804
技术文档
「暂无技术文档」
上下游信息
「暂无上下游信息」
相关文章
「暂无相关文章」
用户评价
加载中...
商品咨询

温馨提示:

因厂家可能临时调整产品规格、价格、库存、参数等信息且不另行通知,同时每位用户的咨询时间、采购需求存在差异,平台回复内容仅在一定时期内具有参考价值。由此给您带来的不便,敬请谅解,感谢您的理解与支持!最新详细信息请咨询在线客服,一切以客服实时回复为准!

售后服务

收到货品请及时核对数量、外观及产品信息,如遇破损、错发、质量异常等问题,欢迎随时联系我们。

服务热线:400-6226-992 ,我们将第一时间为您处理,感谢您的支持与信任!

Verinurad (RDEA3170) 10mM in DMSO 1ml

源叶 Verinurad (RDEA3170) 10mM in DMSO 1ml,1352792-74-5,规格齐全,生产科研实验检测,科学材料数智化一站式易购平台。

品牌:源叶
货号:T93290-1ml
级别: -
货期:30天
已售 367 件
852
.5
937
.8
配送至: 请选择地址
运费:0 元
数量

精选好物